Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Thought Technology Ltd. Featured on Krush Performance Podcast Series Highlighting the Role of the Brain in Peak Performance Training


Krush Performance' peak performance, biofeedback, neurofeedback, hrv

The use of physiological monitoring equipment can be a real game changer for both the athlete and the trainer.

Podcaster and performance consultant, Jeff Krushell, has just released the fourth episode in his podcast series “The Krush Brain Game” in which he explores the brain body connection as it relates to optimal performance.

His belief is that, “We have come a long way in our understanding of human performance but when we look to the future, we feel, it will be new technologies and our understanding of the brain that will push human performance to new heights.”

In the latest installment of the podcast, Jeff sits down with Lucas Borgo, Product Manager at Thought Technology Ltd. who is also a key figure in the development of new apps and software. The company’s products have been used by Olympic and professional athletes and other high performers for decades. According to Lucas, “The use of physiological monitoring equipment can be a real game changer for both the athlete and the trainer. When you are able to see your body’s physiological reaction to stress, you can more easily learn to control this reaction and be confident that the techniques you are using are having the desired effect.”

Included in this ongoing series, are interviews with several influential people from the biofeedback field including: Lawrence Klein, VP and Founder of Thought Technology, Ltd.; Dr. Erik Peper, psychologist, author and president of the Biofeedback Federation of Europe; Dr. Inna Khazan who combines the use of biofeedback and mindfulness; and Dr. Leah Lagos whose focus is on HRV training for athletes and peak performers.

Click here to listen to Jeff Krushell’s interview with Luke Borgo.

About Jeff Krushell

Jeff Krushell is the founder of Krush Performance and an Athlete Development Specialist & Organizational Performance Consultant. He is regarded as a noted expert in the area of talent development in sport and through his work has gained unique insights into the process of improving performance.

Over the last 25 years Jeff has worked in the world of high-performance sport helping athletes tap into their potential to truly understand what it is like to achieve Human Maximum Performance. Jeff currently consults for Major League Baseball International; CTV News, Edmonton; Vauxhall Baseball Academy; Link Management and has previously worked as the strength and conditioning coach for both the Toronto Blue Jays and Edmonton Eskimos.

About Thought Technology Ltd.

Founded in 1975, Thought Technology is the world’s leading biofeedback and physiological instrument manufacturer. Its products are used as an essential part of many therapeutic treatments and clinical assessment protocols in over 85 countries and are used by tens of thousands of clinicians in thousands of medical institutions.

Always supportive of new research and development ideas, Thought Technology Ltd. has encouraged a number of special interest groups and clinicians to create cutting edge applications for its instrumentation. Thought Technology Ltd. equipment is now being used in telemedicine, web-based monitoring and biofeedback, sports training, research in human-machine interface, physiology-driven multimedia environments and virtual reality. Constantly striving to improve the quality of the products and services, TTL has obtained, and maintains, ISO 13485, and CE certification for the organization and products.

Share article on social media or email:

Enso Discoveries, LLC Proudly Announces International Business Expansions in both Veterinary and Human Health Industries


“Having lived and worked overseas for 5 years, I feel I have a great connection to other cultures. It is a passion of mine to offer new innovative products and ideas, as well as learn from so many different cultures with their ideas,” — Patrick Farley, CEO, Enso Discoveries, LLC.

Enso Discoveries, LLC proudly announces its most recent international expansion into Costa Rica with the leading “Pan Latin American Distributor.” This is just one of three major global business developments that the American based biotech company has secured or enhanced during these uncertain times.

“We are very excited to partner with the premier “Pan Latin American” distribution organization in Costa Rica. Our partner has an extensive track record of success in both the veterinary and human medical markets, which will provide both our veterinary and new human health division, Enso Doctors, LLC, an opportunity to grow, along with providing our new partner a unique and prosperous opportunity,” explains Patrick Farley, CEO, Enso Discoveries, LLC.

In addition to a Latin American partnership, over the last few months, Enso Discoveries has been completing an initial assessment required by its new EU partner, based out of Germany. This means the company will be soon entering the EU markets with both the patented PRP (Platelet Rich Plasma) and PRF (Platelet Rich Fibrin) products that are currently distributed in the United States. Both products are rapidly becoming the choice for medical professions due to the ease of use, no new expensive capital needed, science-backed information, and all-inclusive kits that have made these once exclusive services now very affordable to all.

Enso Discoveries is also very proud to announce a new extended 2-year agreement with its Asian veterinary partners that will take the company into 2023, offering Board Certified Histopathology Interpretations. As the company has proven over the last two years to its current Asian partners that there is no substitute for quality interpretations, it anticipates case volume projections to be three to four times that of the current. The current market continues to expand rapidly and Enso Discoveries’ partners purposely direct more cases to their lab for the best in class quality interpretations.

“With a 24-hour or less turnaround time for most cases, we are proud to be helping give veterinarians the ability to make better, faster decisions in an effort to treat their clients’ beloved pets,” says Farley, “As we drive each and every day here in the US to deliver our exceptional products, it is very apparent the demand outside of our country for our unique products is growing rapidly. We remain very excited to deliver the highest quality, most affordable products, to better the health of both animals and humans around the world.”

With the goal of improving quality of life while generating service-based revenues, Enso Discoveries has taken the lead in accessible, unique, affordable and validated regenerative medicine products with Rebound PRP and Rebound PRF in the US and now abroad. Both Rebound PRP and Rebound PRF were designed with veterinarians and physicians in mind. They were validated in a major university, patent-pending and are adjustable therapies to produce a customized amount of PRP or PRF that a patient might need for optimum healing.

Enso Discoveries, LLC is a biotech company focused on enhancing lives through the development of relevant, cost-effective, novel technology that allows our valued customers, to offer better service to all patients and keep their hard-earned business in house. We support our products and services with scientific proof, national distribution partners, and a worldwide network of industry experienced contacts. Ask your distributor about Enso Discoveries, LLC products such as Rebound PRP™ and Rebound PRF® or learn more at http://www.ensodiscoveries.com or http://www.EnsoDoctors.com.

Share article on social media or email:

AseptiScope Announces that Data Presented at October Medical Congresses Support the Use of Aseptic Disk Covers to Protect Against Contaminated Stethoscopes


News Image

The findings further substantiate the stethoscope contamination challenge while supporting the use and effectiveness of touch-free, aseptic, single-use stethoscope disk covers.

AseptiScope™ Inc., a privately funded San Diego, California based clinical innovation company announced today that a study describing the challenge of stethoscope hygiene practices and two studies supporting the use of aseptic disk covers to protect patients from exposure to pathogens on the stethoscope diaphragm are featured at medical conferences in October.

Dr. Frank Peacock, a co-founder of AseptiScope and a co-author of the study featured at the IDSA entitled Effectiveness of Aseptic Stethoscope Barriers in Allowing Clean Contact for Clostridioides Difficile-Contaminated Stethoscope, commented “this important study builds on a body of data supporting the use of aseptic disk covers to protect patients from exposure to pathogens on the stethoscope. By now demonstrating that disk covers are an effective barrier against alcohol-resistant C. difficile spores, we have established the relevance of our solution against one of the most prominent and challenging drug-resistant superbugs that healthcare faces today,” Dr. Peacock added.

“We are pleased to see these two prestigious congresses focus on the longstanding challenge of stethoscope hygiene,” said Scott Mader the CEO and co-founder of AseptiScope. “The findings further substantiate the stethoscope contamination challenge while supporting the use and effectiveness of touch-free, aseptic, single-use stethoscope disk covers. With the upcoming launch of our flagship product, The DiskCover™ System, we look forward to bringing important innovation to this market,” he added.

The details of the data presentations are as follows:

Infectious Disease Society of America IDWeek Virtual Meeting (https://idweek.org)

Poster Name: Effectiveness of Aseptic Stethoscope Barriers in Allowing Clean Contact for Clostridioides Difficile-Contaminated Stethoscope

Poster Session: HAI: Disinfection/Sterilization & Environmental Infection Prevention

Poster Number: 816

Presenter: Rajiv S. Vasudevan, BS

Date: On-Demand as of 21 October 2021

American College of Emergency Physicians Annual Meeting ACEP20 (https://www.acep.org/sa/)

Poster Name: Stethoscope Cleaning Practices and Knowledge Amongst Healthcare Providers

Track: Research

Poster Number: 255

Presenter: Sarathi Kalra, MD

Date: On-Demand as of 26 October 2020

Poster Name: Are Stethoscopes and Infection Control Enemies?

Track: Research

Poster Number: 257

Presenter: Sarathi Kalra, MD

Date: On-Demand as of 26 October 2020

About AseptiScope, Inc.

AseptiScope, formed in early 2016, is a privately funded San Diego, California based, clinical innovation company. The company is founded and led by clinical innovation experts, leading medical researchers and practicing physicians. The AseptiScope mission is to design, develop, manufacture and commercialize novel solutions that ensure “Infection Protection for Clinician & Patient.” The company will introduce the first true and practical solution for the longstanding challenge of stethoscope contamination in autumn of 2020: The DiskCover System™. Visit https://aseptiscope.com for more information.

AseptiScope, DiskCover, and related logos are trademarks of AseptiScope, Inc.

Share article on social media or email:

Nextremity Solutions, Inc. Sees Success with Novel Cut Guide for Lapidus Correction


It was very easy to use the first time and resulted in great correction.

Nextremity Solutions, Inc., a strategic commercialization organization with a focus on the extremity musculoskeletal space, located in “The Orthopedic Capital of the World,” Warsaw, Ind., recently completed the first several cases using their newly launched Lapidus Cut Guide.

The Nextremity Solutions Lapidus Cut Guide is designed to provide anatomically intuitive resection of the first tarsometatarsal joint in preparation for a Lapidus procedure.

Brett Sachs, DPM, FACFAS of Wheat Ridge, Colorado stated, “The new Lapidus Cut Guide allows the surgeon to choose a variety of precise cutting angles to match the patient’s natural anatomy. It also provides limited joint resection to minimize shortening of the metatarsal.”

The Lapidus Cut Guide cutting slots are designed to reduce the amount of resection needed to prepare the joint area by providing surgeons with the flexibility to remove 3-6mm of bone and cartilage. The Lapidus Cut Guide also provides surgeons with a single instrument that allows for unconstrained angle correction based on the individual patient anatomy.

“The Lapidus procedure has seen rapidly increasing surgical options for surgeons treating patients with varying degrees of bunion deformities. This new Lapidus Cut Guide will increase a surgeon’s confidence in making accurate bone cuts in preparation for performing a Lapidus procedure with various systems in the marketplace, including the InCore Lapidus Correction System,” noted Michael Lee, DPM from Des Moines, Iowa.

“I began using the InCore Lapidus System because I preferred the orientation of the compression that is generated by the unique instrumentation while also eliminating patient concerns related to prominent hardware irritation. With the introduction of the new Lapidus Cut Guide from Nextremity Solutions, making parallel cuts on both the medial cuneiform and first metatarsal base will allow reproducible reduction in the inter-metatarsal angle that is the goal in every bunion surgery regardless of the deformity,” commented Keith Tyson, DPM of Hanover, Pennsylvania.

“The new Lapidus Cut Guide just made the Lapidus procedure easy and predictable. It provides confidence in making accurate cuts on both sides of the joint and produced perfect cuts while removing very little bone to prevent shortening of the first ray (metatarsal). It was very easy to use the first time and resulted in great correction,” added Thomas Rappette, DPM of Chicago, Illinois.

The Lapidus Cut Guide is the first technology released by Nextremity Solutions that was entirely manufactured by its manufacturing arm, Lakeland Technology. Lakeland Technology was acquired by Nextremity Solutions, Inc. in March of 2020. Through this relationship with Lakeland Technology, Nextremity Solutions was able to manufacture the Lapidus Cut Guide in a much shorter time frame than was experienced with previous manufacturers.

The patent-pending Lapidus Cut Guide is currently in a limited commercial launch and is exclusively distributed by Nextremity Solutions.

To learn more about this and other products developed by Nextremity Solutions, visit http://www.nextremity.com.

About Nextremity Solutions, Inc.

Nextremity Solutions, Inc. is a privately held strategic commercialization organization with a focus on the extremity musculoskeletal space, offering innovative solutions and Revenue Ready® products for various extremity musculoskeletal applications and for the benefit of our industry partners. The Company’s procedure-ready, sterile implant systems include uniquely precise, proprietary technology designed to achieve repeatable and superior clinical outcomes.

Share article on social media or email:

Local School Districts Look to Crowley for Mask Solutions


Crowley provides sourcing, procurement and delivery of masks, gloves and other PPE for pandemic response by the government and military.

N95 Masks/Shutterstock Image

Like many districts across the state of Arkansas and the nation, one of the Texarkana Arkansas School District goals was to continue to provide a high-quality education to our students in the safest environment possible. Working with Crowley helped us reach that goal.

Crowley Solutions has expanded its pandemic response capabilities to meet the needs of small-scale government users, including local school districts, for personal protective equipment (PPE), such as certified high quality masks.

Crowley is now providing end-to-end supply chain solutions to the military and government agencies – both large and small – placing multi-million-unit orders of masks, gloves and other PPE. To ensure the high-quality, high-demand and NIOSH-approved N95 masks reach government agencies, Crowley safely and completely manages necessary logistics services including sourcing, purchasing, certifying (FDA/CDRH), transporting, customs clearance and delivery.

The company is also scaling PPE services to aid lower-volume government requests. This includes recently supporting two school districts with sourcing, procurement and delivery of certified N95 masks for the Texarkana Arkansas School District and the West York Area School District (Pa.).

“Like many districts across the state of Arkansas and the nation, one of the Texarkana Arkansas School District goals was to continue to provide a high-quality education to our students in the safest environment possible. Working with Crowley helped us reach that goal,” said Dr. Genia Bullock, the district’s director of public relations.

By working with Crowley’s national network of transportation and operations specialists, the districts received hands-on visibility and tracking of their boxed shipments through independent carriers.

Crowley Solutions is a leading provider of energy, maritime, supply chain and technology services for governments. To learn more about Crowley’s pandemic response services, including PPE procurement and supply chain services, visit http://www.crowley.com/covid19-support/.

About Crowley

Jacksonville-based Crowley Holdings Inc., a holding company of the 128-year-old Crowley Maritime Corporation, is a privately held family- and employee-owned company that provides worldwide logistics, government, marine and energy solutions. Crowley operates with four business units. Crowley Logistics is a full-service end-to end supply chain and managed transportation division that also includes ocean liner cargo services utilizing some company-owned vessels. Crowley Shipping encompasses ownership, operations and management of conventional and dual-fuel (liquefied natural gas) vessels, including tankers, container ships, multipurpose vessels, tugboats and barges; engineering, project management and naval architecture; and Crowley LNG, which provides LNG distribution, engineering and related services. Crowley Fuels provides petroleum transportation, distribution and sales primarily throughout Alaska. Crowley Solutions focuses on global government services and program management, government ship management, expeditionary logistics and government-oriented freight transportation services. Additional information about Crowley, its subsidiaries and business units may be found at http://www.crowley.com.

Share article on social media or email:

New Collaboration Yields Next-Gen Evidence-Based Pathways for Leading Urgent Care Provider


News Image

“avoMD helps our clinicians easily access evidence-based guidelines and ultimately enhances patient care,” says Dr. Mordechai Raskas, CMIO of PM Pediatrics.

PM Pediatrics (“PMP”), the nation’s largest provider of specialized pediatric urgent care, is collaborating with avoMD, an app-driven platform for next-gen clinical guidelines and pathways, to improve the adoption of PM Pediatrics’ evidence-based clinical care pathways.

The two parties are digitalizing PM Pediatrics’ clinical guidelines into highly usable and interactive formats, which will be made available on every provider’s phone via the avoMD mobile app. The collaboration will initially focus on twenty clinical targets, including multisystem inflammatory syndrome (MIS-C), urinary tract infection (UTI), acute otitis media (AOM), croup, and asthma.

“avoMD’s platform is an excellent solution to help us translate our team’s clinical expertise into best practice. By transforming our existing guidelines into a simple, interactive app, avoMD helps our clinicians easily access evidence-based medicine and ultimately enhances patient care,” said Dr. Mordechai Raskas, Chief Medical Information Officer and Director of Telemedicine for PM Pediatrics. “Additionally, avoMD’s ability to rapidly update and distribute our guidelines allows us to make changes on the fly and adapt to the rapidly changing clinical environment that COVID-19 has created.”

“PM Pediatrics is a leader in evidence-based pediatric medical care and at the forefront of developing urgent care guidelines,” said Dr. Yair Saperstein, CEO of avoMD. “This collaboration allows PMP providers to instantly access highly contextualized and usable clinical pathways at the point of care, when such content is needed most immediately. We are excited to join forces with PM Pediatrics in developing and delivering this content.”

About PM Pediatrics

Established in 2005, PM Pediatrics is the nation’s largest provider of specialized pediatric urgent care with 60 locations nationwide and over 3,000,000 visits to date. Each location is staffed by pediatric emergency specialists trained in treating newborn through college-age patients for a broad array of illnesses and injuries including asthma, fever, infections, dehydration, fractures, wounds requiring stitches and more. The company’s mission is to provide outstanding clinical care with a focus on minimizing pain and unnecessary tests in a unique office environment tailored for pediatric patients. As part of their commitment to community education, Dr. Christina Johns serves as the company spokesperson and Senior Medical Advisor. As a parent, pediatrician and pediatric emergency physician with a master’s in education, she shares her expertise with patients and families everywhere. PM Pediatrics accepts most types of insurance and features short wait times and convenient hours, 365 days a year. The company is proud to be a nine-time honoree to Inc. magazine’s 500|5000 list of the nation’s fastest-growing private companies. For more information about PM Pediatrics and a list of locations, visit pmpediatrics.com

About avoMD

avoMD is a software platform for next-gen clinical guidelines and pathways. avoMD offers a better way for clinicians to use and learn evidence-based medicine and enables hospitals to distribute and deploy standardized care pathways across its provider base. This next-gen replacement for static and unwieldy guidelines and flowcharts is available via mobile app (iOS and Android) and desktop devices. The PoC App provides clinical information – guidelines, pathways, triaging elements – to providers in highly contextualized and usable formats. avoMD also offers the avoBuilder, an easy-to-use authorship tool that enables instant pathway customization and deployment. Current avoMD partners include leading academic medical centers and urgent care providers, while over 40,000 providers have downloaded the free version of the avoMD app. Recently, avoMD was accepted into Startup Health and 500 Startups, won the annual pitch competitions at Columbia and Penn Medicine, and received a large investment from Columbia University’s endowment.

For more information, visit http://www.avomd.io.

Download the iOS App or Google Play App.

Follow avoMD on LinkedIn, Facebook, and Twitter.

Share article on social media or email:



West Offers Patients Even More Oncology Treatment Options


News Image

It’s an exciting time for cancer research, and this new initiative will give our patients and their families more treatment options than ever before!

As an affiliate of OneOncology, West Cancer Center & Research Institute now has the ability to further its clinical trial offerings and oncology research knowledge by joining the launch of OneR.

OneR is a new, unprecedented technology platform and collaboration throughout the OneOncology network that provides seamless clinical trial management, increased access to trial therapies for patients, and more oncology research information readily available to our clinicians. Patients can participate in clinical trials for specific cancer types, in an effort to decrease side effects of current treatments, or with aims to improve disease outcomes – and now, with the implementation of OneR, these efforts are supported more than ever before.

Mitch Graves, CEO of West Cancer Center states, “We are incredibly excited to join the launch of OneR! This new platform allows us to offer more clinical trials to patients in need by centralizing business functions, regulatory submissions, and clinical trial matching technology while also maintaining our flexibility to participate in other clinical trial initiatives managed by our in-house Clinical Research Department. It’s an exciting time for cancer research, and this new initiative will give our patients and their families more treatment options than ever before!”

Recently, West added “Research Institute” to its name to ensure the priority and focus it has on clinical research was made apparent and embedded into its culture. This new opportunity only further promotes its many initiatives to increase oncology research across the globe.

Share article on social media or email:

Preferred Health Insurance Solutions Provides Tips To Assist Individuals Who Enroll In The Upcoming 2021 Marketplace Open Enrollment Period


News Image

In addition to the cost for monthly health insurance premiums, an individual also needs to look at other out of pocket expenses such as deductibles, co-insurance limits and prescription drug coverage

“2020 was an unprecedented year with the coronavirus and the nationwide job loss that followed. With so many individuals losing their job-based health insurance, it is essential individuals seek the direction of a licensed health insurance professional who is trained to walk a client through the entire process of selecting a healthcare plan and enrolling for coverage,” began Robert Dial, vice president, Preferred Health Insurance Solutions (PHIS), formally known as ACA Marketplace Enrollment Solutions (ACAEnroll.com).    

“A licensed health insurance professional can also help the individual select a plan that meets their needs and budget. In addition to the cost for monthly health insurance premiums, an individual also needs to look at other out of pocket expenses such as deductibles, co-insurance limits and prescription drug coverage,” Dial added.    

The 2021 Open Enrollment Period (OEP) runs from Sunday, November 1st to Tuesday, December 15, 2020. Individuals who do not enroll by December 15th cannot get a marketplace health insurance plan unless they have a qualifying event under the Special Enrollment Period. In order to help individuals begin this process, Dial outlines some critical steps and important deadlines.

Tip 1: Begin by reviewing your current 2020 health insurance plan. Important information to think through includes:

a. Does my current health insurance plan still meet my individual or family needs?

b. Since selecting my 2020 health insurance plan, have there been any new health challenges my family or I now face?

c. Have there been any financial changes?

d. Are the doctors my family or I receive care from still within the network or covered on my 2021 health insurance plan?

Tip 2: Work with a certified insurance broker who can help you select a policy for the new calendar year. Dial add, “After this evaluation step is completed, seek out the direction of a licensed health insurance professional. PHIS’s certified insurance brokers are able to walk a client through the entire process of selecting a healthcare plan and enrolling them for coverage. PHIS will be able to respond to any questions you may have regarding your 2021 health insurance policy”.

Tip 3: Be aware of important deadlines and dates outlined by the federal government. These dates include:

a. Sunday, November 1st: marks the first day you can enroll, re-enroll, or change a 2021 insurance plan through the Health Insurance Marketplace.

b. Tuesday, December 15th: OEP closes.

c. Friday, January 1st, 2021: The date when 2021 health insurance plan coverage begins.

Tip 4: Gather all necessary documents that are required in order to complete the health insurance registration process. The following documents will be needed for each member named in the policy:

a. Prior to starting the application, determine who in your household needs to apply or re-enroll for coverage.

b. Information about everyone applying for coverage such as home address, Social Security Numbers, birthdates.

c. For re-enrollees, policy numbers and plan IDs, for any current health plans covering members of the household.

d. Document information for legal immigrants.

e. Information about how taxes are filed. To reference, having past tax documents available will help ensure financial information is entered correctly.

f. Employer and income information for every member of your household that will be included on the policy. Pay stubs or W2 forms will need to be provided.

Dial explained, “Purchasing health insurance through the Marketplace can be a confusing process. There are several factors, government rules, and provisions to consider before purchasing health insurance. The OEP provides consumers the ability to shop for new plans and enroll for coverage. This is the only time consumers can purchase a qualified, guaranteed issue, Major Medical Health Plan, without a qualifying event.”

The certified insurance brokers at PHIS are prepared to assist consumers with all their enrollment needs. The dedicated PHIS Call Center consists of a team of multilingual, licensed health insurance professionals, who are trained to walk a client through the entire process of selecting a healthcare plan and enrolling them for their coverage, as well as responding to any questions they may have regarding their new health insurance policy. The PHIS Call Center will be available to assist consumers enrolling for their 2021 health plan. Consumers can call the PHIS Call Center at 800-342-0631 or access the company’s website at https://www.PHISonline.com.

About Preferred Health Insurance Solutions

Headquartered in Bedford Park, Illinois, Preferred Health Insurance Solutions (PHIS) is a national enrollment firm specializing in the Health Insurance Marketplace as well as a variety of other health insurance products including: Dental, Critical Illness; Short Term Major Medical; and others. PHIS, formerly known as ACA Marketplace Enrollment Solutions (ACAEnroll.com) provides enrollment services throughout the country, through national and regional insurance carriers. Consumers can call the PHIS Call Center at 800-342-0631 or access the company’s website at https://www.PHISonline.com.

Share article on social media or email:

One year in, BW Consulting offers tools for launch success for small to mid-size life sciences innovators


News Image

“We’ve been in their shoes and can understand what they are confronting and what they need,” said Tom McDonnell, President of BW Health Group. “We become the extended team.”

The speed at which therapeutic advances have been made in a digitally transformed COVID 19 world requires industry acumen and marketing expertise that can guide brand leaders in the life sciences to commercial success. Celebrating one year as the healthcare consulting practice under the BW Health Group umbrella of enterprises, BW Consulting is built to respond with speed, scale and expertise. While expanding their reach across a range of therapeutic categories, BW Consulting remains hyper-focused on its core offering: a toolkit for diagnosing launch preparedness followed by a customized path to launch excellence for life sciences clients.

In the past year, the consulting team of former pharma commercial leads and strategists has spent a lot of time helping clients reimagine engagement strategies for the virtual world. At the same time, they have built a rigorous platform that supports clients through product prelaunch, launch and post-launch, the latter of which can be a critical make-or-break milestone for brands.

“Only 20% of products improve their sales trajectories 6 months post-launch,” explained Joe Medel, SVP Strategy for BW Consulting. “It’s critical to set the right course well in advance to ensure sustained success for the brand going forward.”

Therapeutic experience among the team includes orphan drugs, gene therapy, immunotherapies in oncology and novel treatments in rare disease. Many of the smaller to mid-size companies innovating in these areas struggle with resources, budgets and prioritization of commercial goals. BW Consulting specializes in providing solutions to clients who may lack the infrastructure or budget to support a marketing team.

“We’ve been in their shoes and can understand what they are confronting and what they need,” said Tom McDonnell, President of BW Health Group. “We become the extended team.”

“Some of the biggest innovations are coming from small life sciences firms that need that kind of strategic augmentation to help their brands get off the ground,” Medel added. “There is no substitute for effective prelaunch prep, ever—especially in this COVID19 world.”

More information on the specifics of the firm’s launch excellence approach, as well as a launch navigation tool designed to begin the conversation on launch readiness, can be found on their new website, ConsultBW.com.

####

About BW Consulting

BW Consulting is a healthcare consulting team consisting of management consulting pros, former pharma commercial leads, technology experts and scientists. BW consultants leverage their experience as brand leaders to help small to mid-size innovators in the pharma, biotech and medical device space to achieve launch excellence and sustained success for their brands through the use of a focused set of tools that diagnose and help customize launch planning and execution.

For additional information, please call 800-536-4670 or visit ConsultBW.com

About BW Health Group

BW Health Group is dedicated to advancing the commercial goals of life sciences clients through a family of companies providing award-winning strategy, creative, and execution for life sciences brands as well as pharmaceutical distribution, technology and commercialization services. BW Health Group includes Benchworks, a full-service marketing and communications agency and BW Consulting, a life sciences consulting division. BW Health Group also has a strategic partnership with Occam Health, an independent patient services provider. For additional information, please visit http://www.bwhealthgroup.com.

Share article on social media or email:

Caravan Health Announces Speaker Lineup for Fifth Annual Accountable Care Symposium


“In this most unusual year, learning to manage change and adapt quickly is more important than ever. I look forward to connecting again with Caravan Health and their partners as they chart a path forward in value-based care,” said Quint Studer, best-selling author and health care thought leader.

Caravan Health will host its fifth Accountable Care Symposium, the first held virtually, for thought leaders, decision makers, and frontline practitioners in accountable care from across the nation. From December 7-10, health care visionaries will have the opportunity to listen to keynote speakers, learn best practices from peers, and watch and support awards presentations.

Among the confirmed speakers are:

  • Dr. Patrick Conway, Chief Executive Officer, Care Solutions at Optum
  • Dr. Rahul Rajkumar, Senior Vice President Chief Medical Officer, BlueCross BlueShield of North Carolina
  • Dr. Kyu Rhee, Chief Medical Officer, IBM Watson Health
  • Joe Scarborough, MSNBC commentator and host of Morning Joe
  • Brock Slabach, Senior Vice President, National Rural Health Association
  • Quint Studer, Founder, Studer Group


“Trust and communication are at the core of any organization’s success,” said Quint Studer, best-selling author and health care thought leader. “In this most unusual year, learning to manage change and adapt quickly is more important than ever. I look forward to connecting again with Caravan Health and their partners as they chart a path forward in value-based care.”

Dr. Kyu Rhee, the Chief Medical Officer at IBM Watson Health, has worked extensively in community health and equity while reinventing the culture of health care. He is highly-respected in the industry and has encouraged the transition from value-based care to “values based care”.

“It’s no longer enough to provide patient care,” commented Dr. Rhee. “Using technology will open new doors so that we continue delivering high-quality, sustainable values-based care in the new year.”

The four-day virtual event will combine four different learning topics geared to all levels of ACO experience and a wide range of organizational roles. These topics include program and policy updates, best practices for better patient care, strategies for financial success and sustainability and innovations in technology. On December 9, Former Congressman (R-FL) and co-host of MSNBC’s “Morning Joe”, Joe Scarborough, will share his perspectives on what our nation can expect in 2021.

Dr. Patrick Conway, CEO of Care Solutions at Optum, is scheduled to speak on improving patient care and will focus part of his presentation on redemption after failure. Prior to Optum, Dr. Conway was the CEO of BlueCross BlueShield of North Carolina and before that was Chief Medical Officer, Deputy Administrator and Director for Medicare and Medicaid Innovation at Centers for Medicare & Medicaid Services (CMS).

Dr. Conway added: “The symposium is an incredible opportunity for health care leaders across the country to learn how to secure their future in risk-based payment models, and connect with top practitioners and experts in population health. I’m passionate about how to improve patient care using value-based care models and looking forward to connecting with colleagues at the event.”

Learn more and register today at http://www.caravanhealth.com/symposium

About Caravan Health: Caravan Health helps providers make accountable care work regardless of their size, location, history, or demographics. Caravan Health gives community health systems and providers a way to create more scale, drive more change, and generate more revenue. The 250+ health systems who have turned to Caravan achieved single-year savings greatly exceeding the national average. Health systems and providers across the country are using our proven population health programs to ensure better outcomes for their patients every day. With Caravan Health, now the numbers work. For more information visit http://www.caravanhealth.com.

Share article on social media or email: